Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (44)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Luiro, K.
Right arrow Articles by Jalanko, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Luiro, K.
Right arrow Articles by Jalanko, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2001, Vol. 10, No. 19 2123-2131
© 2001 Oxford University Press

CLN3 protein is targeted to neuronal synapses but excluded from synaptic vesicles: new clues to Batten disease

Kaisu Luiro, Outi Kopra, Maarit Lehtovirta1 and Anu Jalanko+

National Public Health Institute, Department of Molecular Medicine, Biomedicum Helsinki, PO Box 104, Haartmaninkatu 8, FIN-00251 Helsinki, Finland and 1Department of Neurology, Kuopio University Hospital, 70211 Kuopio, Finland

Batten disease (juvenile neuronal ceroid lipofuscinosis, JNCL), the most common neurodegenerative disease of childhood, is caused by mutations in the CLN3 gene encoding a putative transmembrane protein. The function of CLN3 is currently unknown but it has been shown to localize in the endosomal/lysosomal compartments of non-neuronal cells. In addition, several other intracellular localizations have been proposed and the controversy of the reports suggests that CLN3 may have different intracellular localization in different cell types. Batten disease severely affects neuronal cells but leaves other organs clinically unaffected, and thus it is of utmost importance to approach the disease mechanism by studying the expression and localization of CLN3 in the brain and neuronal cells. We have analysed here CLN3 in the mouse brain using in situ hybridization, immunohistochemical staining and western blot analysis of subcellular fractions. As visual deterioration is the hallmark of Batten disease we have set up primary retinal cultures from the mouse and analysed both endogenous mouse CLN3 and Semliki Forest virus-mediated human CLN3 localization using immunofluorescence staining and confocal microscopy. We demonstrate that CLN3 is abundantly expressed in neuronal cells, especially in the cortex, hippocampus and cerebellum of the adult mouse brain. Furthermore, our results indicate that in neurons CLN3 is not solely a lysosomal protein. It is localized in the synaptosomes but, interestingly, is not targeted to the synaptic vesicles. The novel localization of CLN3 directs attention towards molecular alterations at the synapses. This should yield important clues about the mechanisms of neurodegeneration in Batten disease.

+ To whom correspondence should be addressed. Tel: +358 9 47448392; Fax: +358 9 47448480; Email: anu.jalanko@ktl.fi


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Cell Sci.Home page
S. Codlin and S. E. Mole
S. pombe btn1, the orthologue of the Batten disease gene CLN3, is required for vacuole protein sorting of Cpy1p and Golgi exit of Vps10p
J. Cell Sci., April 15, 2009; 122(8): 1163 - 1173.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
Y. Takada, C. Vijayasarathy, Y. Zeng, S. Kjellstrom, R. A. Bush, and P. A. Sieving
Synaptic Pathology in Retinoschisis Knockout (Rs1-/y) Mouse Retina and Modification by rAAV-Rs1 Gene Delivery
Invest. Ophthalmol. Vis. Sci., August 1, 2008; 49(8): 3677 - 3686.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
S. L. Eliason, C. S. Stein, Q. Mao, L. Tecedor, S.-L. Ding, D. M. Gaines, and B. L. Davidson
A Knock-In Reporter Model of Batten Disease
J. Neurosci., September 12, 2007; 27(37): 9826 - 9834.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
B. Karten, R. B. Campenot, D. E. Vance, and J. E. Vance
The Niemann-Pick C1 protein in recycling endosomes of presynaptic nerve terminals
J. Lipid Res., March 1, 2006; 47(3): 504 - 514.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
Y. Gachet, S. Codlin, J. S. Hyams, and S. E. Mole
btn1, the Schizosaccharomyces pombe homologue of the human Batten disease gene CLN3, regulates vacuole homeostasis
J. Cell Sci., December 1, 2005; 118(23): 5525 - 5536.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
G. Salazar, B. Craige, B. H. Wainer, J. Guo, P. De Camilli, and V. Faundez
Phosphatidylinositol-4-Kinase Type II {alpha} Is a Component of Adaptor Protein-3-derived Vesicles
Mol. Biol. Cell, August 1, 2005; 16(8): 3692 - 3704.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Kyttala, K. Yliannala, P. Schu, A. Jalanko, and J. P. Luzio
AP-1 and AP-3 Facilitate Lysosomal Targeting of Batten Disease Protein CLN3 via Its Dileucine Motif
J. Biol. Chem., March 18, 2005; 280(11): 10277 - 10283.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Storch, S. Pohl, and T. Braulke
A Dileucine Motif and a Cluster of Acidic Amino Acids in the Second Cytoplasmic Domain of the Batten Disease-related CLN3 Protein Are Required for Efficient Lysosomal Targeting
J. Biol. Chem., December 17, 2004; 279(51): 53625 - 53634.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
K. Luiro, K. Yliannala, L. Ahtiainen, H. Maunu, I. Jarvela, A. Kyttala, and A. Jalanko
Interconnections of CLN3, Hook1 and Rab proteins link Batten disease to defects in the endocytic pathway
Hum. Mol. Genet., December 1, 2004; 13(23): 3017 - 3027.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
S. B. Narayan, J. V. Pastor, H. M. Mitchison, and M. J. Bennett
CLN3L, a novel protein related to the Batten disease protein, is overexpressed in Cln3-/- mice and in Batten disease
Brain, August 1, 2004; 127(8): 1748 - 1754.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
A. Kyttala, G. Ihrke, J. Vesa, M. J. Schell, and J. P. Luzio
Two Motifs Target Batten Disease Protein CLN3 to Lysosomes in Transfected Nonneuronal and Neuronal Cells
Mol. Biol. Cell, March 1, 2004; 15(3): 1313 - 1323.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
C. C. Wreden, J. Johnson, C. Tran, R. P. Seal, D. R. Copenhagen, R. J. Reimer, and R. H. Edwards
The H+-Coupled Electrogenic Lysosomal Amino Acid Transporter LYAAT1 Localizes to the Axon and Plasma Membrane of Hippocampal Neurons
J. Neurosci., February 15, 2003; 23(4): 1265 - 1275.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
S. L. Cotman, V. Vrbanac, L.-A. Lebel, R. L. Lee, K. A. Johnson, L.-R. Donahue, A. M. Teed, K. Antonellis, R. T. Bronson, T. J. Lerner, et al.
Cln3 {Delta}ex7/8 knock-in mice with the common JNCL mutation exhibit progressive neurologic disease that begins before birth
Hum. Mol. Genet., October 15, 2002; 11(22): 2709 - 2721.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
D.-A. N. W. Persaud-Sawin, A. VanDongen, and R.-M. N. Boustany
Motifs within the CLN3 protein: modulation of cell growth rates and apoptosis
Hum. Mol. Genet., September 1, 2002; 11(18): 2129 - 2142.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
J. Vesa, M. H. Chin, K. Oelgeschlager, J. Isosomppi, E. C. DellAngelica, A. Jalanko, and L. Peltonen
Neuronal Ceroid Lipofuscinoses Are Connected at Molecular Level: Interaction of CLN5 Protein with CLN2 and CLN3
Mol. Biol. Cell, July 1, 2002; 13(7): 2410 - 2420.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
J. Isosomppi, J. Vesa, A. Jalanko, and L. Peltonen
Lysosomal localization of the neuronal ceroid lipofuscinosis CLN5 protein
Hum. Mol. Genet., April 15, 2002; 11(8): 885 - 891.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.